Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy

Effective treatment options in advanced/progressive/metastatic medullary thyroid carcinoma (MTC) are currently limited. As in other neuroendocrine neoplasms (NENs), peptide receptor radionuclide therapy (PRRT) has been used as a therapeutic option in MTC. To date, however, there are no published rev...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Med
Autori principali: Grossrubatscher, Erika, Fanciulli, Giuseppe, Pes, Luca, Sesti, Franz, Dolci, Carlotta, de Cicco, Federica, Colao, Annamaria, Faggiano, Antongiulio
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7693147/
https://ncbi.nlm.nih.gov/pubmed/33138305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9113507
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi